comparemela.com

Latest Breaking News On - Cassava sciences inc - Page 8 : comparemela.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc of Class Action Lawsuit and Upcoming Deadlines

/PRNewswire/ (PRNEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company").

Tel avivFrance generalUnited statesNew yorkCity ofUnited kingdomAbrahaml pomerantzDanielle peytonLos angelesCity university of new yorkSecurities exchangeUnited states food drug administrationCassava sciences incUnited states district courtCassava sciencesNorthern district

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA

NEW YORK, March 27, 2024 /PRNewswire/ WHY: Rosen Law Firm, a global investor.

New yorkUnited statesLaurence rosenPhillip kimChinese companySecurities class action servicesRosen law firmCassava sciences incCassava sciencesClass periodLaw firmClass action servicesClass has been

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action

/PRNewswire/ WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between.

New yorkUnited statesLaurence rosenPhillip kimRosen law firmSecurities class action servicesChinese companyCassava sciences incCassava sciencesClass periodLaw firmClass action servicesClass has beenThe rosen law firm

IMMINENT SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava

IMMINENT SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava .

Gewirtz grossman llcperetz bronsteinGewirtz grossmanYael nathansonPeretz bronsteinNews networkCassava sciences incCassava sciencesClass period defendantsLaw clerkClient relations manager

Cassava Sciences (SAVA) Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

Cassava Sciences (SAVA) Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Puerto ricoSouth koreaRemi barbierCassava sciencesCassava sciences incResearch internationalSafety monitoring boardCassava sciencePremier research international

vimarsana © 2020. All Rights Reserved.